Security key
92840H400
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)
CUSIP: 92840H400
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 14,643,797
- Total 13F value
- $44,079,533
- Share change
- +1,589,738
- Put/Call ratio
- 438%
- SEC-reported price per share
- $3.01
- Number of holders
- 47
- Value change
- +$4,636,495
- Number of buys
- 17
- Number of sells
- 16
- Shares outstanding
- 42,874,646
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
47
Top holders
10
VTGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Vistagen Therapeutics, Inc. SEC filings
Vistagen Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92840H400
Recent filing periods:
Ownership snapshot
Top reported holders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Healthcare Capita...
Disclosed value leader
Venrock Healthcare Capita...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $35,434,220
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Venrock Healthcare Capital Partners II, L.P. has the largest disclosed position value at $35.43M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Healthcare Capital Partners II, L.P.'s linked filing trail.
Disclosed position value
Top 5
Venrock Healthcare Capital Partne...
$35.43M
Commodore Capital LP
$5.48M
TCG Crossover Management, LLC
$9.31M
BVF INC/IL
$6.96M
VANGUARD GROUP INC
$6.24M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners II, L.P. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$35,434,220
20,637,286 shares
|
— | 12 Jul 2022 |
| Commodore Capital LP |
13F
3/4/5
Company · 10%+ Owner
|
—
mixed-class rows
|
$5,481,000
1,575,000 shares
|
— | 30 Jun 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
—
denominator unverified
|
$9,314,499
2,676,580 shares
|
— | 30 Jun 2024 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$6,960,000
2,000,000 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$6,240,217
1,793,166 shares
|
— | 30 Jun 2024 |
| STEMPOINT CAPITAL LP |
13F
Company
|
—
denominator unverified
|
$5,848,164
1,848,582 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
47
Shares
14,643,797
Rows available
47
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
42
Q3 2024 holders
47
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend